CBD Life Sciences Inc. (CBDL) .
本页证实的标准:
SharesGrow 综合评分： 34/100 其中 1/7 项标准通过。
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2012 | $-2,405.14 | $0.00 | $-156.33K | - |
| 2013 | $-2,294.59 | $155.55K | $-367.14K | -236% |
| 2014 | $-428.18 | $122.79K | $-780.14K | -635.3% |
| 2019 | $-0.01 | $79.64K | $-861.01K | -1081.2% |
| 2020 | $0.00 | $225.9K | $-1.69M | -750.1% |
| 2021 | $0.00 | $59.26K | $-5.13M | -8654.2% |
| 2022 | $0.00 | $160.24K | $-859.8K | -536.6% |
| 2023 | $0.00 | $167.15K | $-78.57K | -47% |
| 2024 | $0.00 | $108.89K | $-757.19K | -695.4% |
| 2025 | $0.00 | $98.32K | $-48.93K | -49.8% |
